MosaiQ® Abstract Presented at Annual ACR Convergence Meeting

AliveDx Suisse S.A. and Medlinks Consulting Joint Stock Company have signed a distribution agreement, which will enable Medlinks to distribute the MosaiQ® solution in South Vietnam. The distribution agreement takes effect immediately. AliveDx is dedicated to expanding its reach and

We are excited to announce that our abstract titled “Performance characteristics of a novel, fully automated immunoassay microarray for the qualitative serological detection of specific IgE directed against Bet v 1” has been accepted by the European Congress of Immunology

AliveDx Suisse S.A. and Patho Solutions Malaysia Sdn. Bhd. have signed a distribution agreement, which will enable Patho Solutions Malaysia to distribute the MosaiQ® solution in Malaysia. The distribution agreement takes effect immediately. AliveDx is dedicated to expanding its reach

AliveDx Suisse S.A. and Everlight Biotech Co. Ltd. have signed a distribution agreement, which will enable Everlight Biotech Co. Ltd. to distribute the MosaiQ® solution in Taiwan. The distribution agreement takes effect immediately. AliveDx is dedicated to expanding its reach

At AliveDx, we understand that the success of our business is closely linked to the wellbeing of the communities in which we operate. Our goal is to advance sustainable practices in every aspect of our operations. We are pleased to

AliveDx Suisse S.A. and Ozgun Kimya A.S. have signed a distribution agreement, which will enable Ozgun Kimya A.S. to distribute the MosaiQ® solution in Türkiye. The distribution agreement takes effect immediately. This strategic partnership reaffirms AliveDx’s consistent commitment to grow